Prednisolone Swish and Spit Regimen
For oral lesions, use prednisolone oral solution 15 mg/5 mL (or equivalent concentration): swish 10 mL for 2-3 minutes and spit, one to four times daily. This regimen is based on established guidelines for managing oral mucosal disease, though the evidence specifically cites betamethasone sodium phosphate as the corticosteroid of choice 1.
Specific Dosing Protocol
The British Association of Dermatologists guidelines recommend betamethasone sodium phosphate 0.5 mg dissolved in 10 mL of water as a 2-3 minute rinse-and-spit solution one to four times daily for oral lesions in pemphigus vulgaris 1. When prednisolone is substituted, the equivalent concentration would be approximately 15 mg/5 mL oral solution, using 10 mL per rinse.
Administration Instructions:
- Volume: 10 mL per rinse
- Duration: 2-3 minutes of swishing
- Frequency: 1-4 times daily (titrate based on severity)
- Technique: Swish thoroughly throughout oral cavity, then expectorate—do not swallow
- Timing: Consider using before meals if eating is painful
Clinical Context and Adjustments
Start with 4 times daily for moderate to severe oral lesions, then reduce frequency as symptoms improve. For mild disease, 1-2 times daily may suffice 1.
Important Caveats:
Dilution may be necessary: If the solution causes discomfort or burning, dilute by 50% with water 1. This is particularly relevant since prednisolone oral solution contains 1.8% alcohol 2.
Duration of therapy: Continue until oral lesions heal or symptoms resolve to grade 1, typically requiring several weeks to months. Taper frequency gradually rather than stopping abruptly 3.
Adjunctive measures: Combine with good oral hygiene (gentle tooth brushing twice daily, chlorhexidine rinse if tolerated), dietary modifications (avoid spicy, acidic, crunchy, or hot foods), and consider viscous lidocaine or "magic mouthwash" for pain control 4, 3.
Alternative Formulations
If prednisolone is unavailable or poorly tolerated, alternatives include:
- Dexamethasone 0.1 mg/mL (0.5 mg/5 mL): 10 mL swish and spit 4 times daily 4, 5
- Fluticasone propionate nasules: Diluted in 10 mL water twice daily 1
- Clobetasol 0.05% gel: For localized lesions on dried mucosa 1
Evidence Quality and Limitations
The evidence for topical corticosteroid mouthwashes is Level 3 (Strength D) 1. While widely used as adjunctive therapy, controlled studies demonstrating additional benefit beyond systemic therapy are lacking 1. However, clinical experience supports their use for symptom control and quality of life improvement, particularly in patients with isolated oral disease or as steroid-sparing adjuncts.
Recent research supports prophylactic use: A 2019 randomized trial showed prednisolone mouthwash (15 mg/5 mL, 10 mL four times daily) significantly reduced stomatitis incidence in cancer patients receiving mTOR inhibitors 2. A 2020 study demonstrated prednisolone mouthwash improved mouth opening and reduced burning sensation in oral submucous fibrosis 6.
Monitoring and Safety
- Systemic absorption is minimal with swish-and-spit technique, but prolonged use may still cause local candidiasis
- Consider antifungal prophylaxis (nystatin or clotrimazole) if using for >2-4 weeks
- Monitor for oral candidiasis (white patches, altered taste)
- If no improvement after 2-3 weeks, consider referral to dermatology or oral medicine 3